Suppr超能文献

抗抑郁药在双相情感障碍中的应用。

The use of antidepressants in bipolar disorder.

作者信息

Salvi Virginio, Fagiolini Andrea, Swartz Holly A, Maina Giuseppe, Frank Ellen

机构信息

Department of Neuroscience, University of Turin, Italy.

出版信息

J Clin Psychiatry. 2008 Aug;69(8):1307-18. doi: 10.4088/jcp.v69n0816.

Abstract

BACKGROUND

Whether or not to use antidepressants in patients with bipolar disorder is a matter of debate. Antidepressant treatment of bipolar depression has been associated with manic switch and cycle acceleration. Furthermore, recent studies have argued against the efficacy of antidepressants in the treatment of bipolar depression. Nevertheless, many clinicians continue to employ antidepressants, especially in the management of severe depression that is unresponsive to mood stabilizers alone.

OBJECTIVE

Because of the unclear risk-to-benefit ratio of antidepressants in bipolar disorder, we have performed an updated review of the relevant literature. In this article we examine (1) all randomized controlled trials (RCTs) evaluating the use of antidepressants in the treatment of acute bipolar depression and assessing the risk of antidepressant-induced manic switch and (2) non-RCT trials that evaluate the impact of antidepressant discontinuation after acute antidepressant response.

DATA SOURCES

A MEDLINE search of journals, covering the period from January 1966 to July 2007 and supplemented by bibliographic cross-referencing, was performed to identify the relevant studies. The keywords used were antidepressant, bipolar depression, bipolar disorder, switch, manic switch, antidepressant-induced mania, predictors, and antidepressant discontinuation. Criteria used to select studies included (1) English language and (2) studies published in peer-reviewed journals.

DATA SYNTHESIS

Randomized, double-blind, placebo-controlled studies have demonstrated that antidepressants exert some efficacy in the treatment of bipolar depression in some populations of patients. Moreover, the risk of manic switch, although not totally countered, appears to be strongly reduced when antidepressants are given in combination with a mood stabilizer and when new-generation antide-pressants are preferred over old tricyclic antidepressants. Finally, some studies have proven that the continuous use of antidepressants after the remission of a major depressive episode helps to prevent further depressive relapses without causing a significant increase in manic relapses.

CONCLUSIONS

Clearly, there is a place for antidepressants in bipolar disorder; however, it is important to be cautious and evaluate their use on a case-by-case basis. Looking at specific depressive symptoms might help physicians in making the choice of whether to prescribe or not prescribe antidepressants.

摘要

背景

双相情感障碍患者是否使用抗抑郁药一直存在争议。双相抑郁的抗抑郁治疗与躁狂发作及病程加速有关。此外,近期研究对抗抑郁药治疗双相抑郁的疗效提出质疑。然而,许多临床医生仍继续使用抗抑郁药,尤其是在治疗对单独使用心境稳定剂无反应的重度抑郁时。

目的

由于双相情感障碍中使用抗抑郁药的风险效益比尚不明确,我们对相关文献进行了更新综述。在本文中,我们研究了:(1)所有评估抗抑郁药治疗急性双相抑郁并评估抗抑郁药诱发躁狂发作风险的随机对照试验(RCT);(2)评估急性抗抑郁反应后停用抗抑郁药影响的非RCT试验。

数据来源

对1966年1月至2007年7月期间的期刊进行了MEDLINE检索,并通过文献交叉引用进行补充,以确定相关研究。使用的关键词为抗抑郁药、双相抑郁、双相情感障碍、发作、躁狂发作、抗抑郁药诱发的躁狂、预测因素和停用抗抑郁药。选择研究的标准包括:(1)英文文献;(2)发表在同行评审期刊上的研究。

数据综合

随机、双盲、安慰剂对照研究表明,抗抑郁药在某些双相抑郁患者群体中具有一定疗效。此外,虽然不能完全消除躁狂发作风险,但当抗抑郁药与心境稳定剂联合使用且优先选择新一代抗抑郁药而非老式三环类抗抑郁药时,躁狂发作风险似乎会大幅降低。最后,一些研究证明,在重度抑郁发作缓解后持续使用抗抑郁药有助于预防进一步的抑郁复发,且不会显著增加躁狂复发风险。

结论

显然,抗抑郁药在双相情感障碍治疗中有一席之地;然而,谨慎并根据具体情况评估其使用非常重要。关注特定的抑郁症状可能有助于医生决定是否开具抗抑郁药。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验